Skip to main content
NCBI home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1974;50(3-4):203–212.

Clinical testing of new antimalarial compounds*

C J Canfield, R S Rozman
PMCID: PMC2481191  PMID: 4613503

Abstract

More than 200 000 chemical compounds have been screened for antimalarial activity over the past 10 years by the US Army Antimalarial Drug Development Program. By means of extensive animal testing, 26 of these compounds were selected for clinical study in human subjects volunteering for such trials. Of these, 7 have received complete clinical trials and are in various stages of field evaluation, 4 are currently undergoing clinical trial, and 2 are still awaiting testing in volunteer subjects. Thus far, 2 compounds (WR 33 063 and WR 30 090) have demonstrated greater activity against drug-resistant Plasmodium falciparum than any other known drug. Several other compounds presently being tested in human subjects are even more potent.

Full text

PDF
203

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnold J. D., Martin D. C., Carson P. E., Rieckmann K. H., Willerson D., Jr, Clyde D. F., Miller R. M. A phenanthrene methanol (WR 33063) for treatment of acute malaria. Antimicrob Agents Chemother. 1973 Feb;3(2):207–213. doi: 10.1128/aac.3.2.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Canfield C. J., Hall A. P., MacDonald B. S., Neuman D. A., Shaw J. A. Treatment of falciparum malaria from Vietnam with a phenanthrene methanol (WR 33063) and a quinoline methanol (WR 30090). Antimicrob Agents Chemother. 1973 Feb;3(2):224–227. doi: 10.1128/aac.3.2.224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Clyde D. F., Rebert C. C., McCarthy V. C., Dawkins A. T., Jr, Cucinell S. A. Diformyl diaminodiphenyl sufone (DFD) as an antimalarial in man. Mil Med. 1970 Jul;135(7):527–536. [PubMed] [Google Scholar]
  4. Clyde D. F., Rebert C. C., McCarthy V. C., Miller R. M. Prophylaxis of malaria in man using the sulfone DFD with pyrimethamine. Mil Med. 1973 Jul;138(7):418–421. [PubMed] [Google Scholar]
  5. Clyde D. F., Rebert C. C., McCarthy V. C., Miller R. M. Prophylaxis of malaria in man using the sulfones DFD and DDS alone and with chloroquine. Mil Med. 1971 Nov;136(11):836–841. [PubMed] [Google Scholar]
  6. Degowin R. L., Eppes R. B., Carson P. E., Powell R. D. The effects of diaphenylsulfone (DDS) against chloroquine-resistant Plasmodium falciparum. Bull World Health Organ. 1966;34(5):671–681. [PMC free article] [PubMed] [Google Scholar]
  7. Degowin R. L., Eppes R. B., Powell R. D., Carson P. E. The haemolytic effects of diaphenylsulfone (DDS) in normal subjects and in those with glucose-6-phosphate-dehydrogenase deficiency. Bull World Health Organ. 1966;35(2):165–179. [PMC free article] [PubMed] [Google Scholar]
  8. Eppes R. B., McNamara J. V., DeGowin R. L., Carson P. E., Powell R. D. Chloroquine-resistant Plasmodium falciparum: protective and hemolytic effects of 4,4'-diaminodiphenylsulfone (DDS) administered daily together with weekly chloroquine and primaquine. Mil Med. 1967 Mar;132(3):163–175. [PubMed] [Google Scholar]
  9. Joy R. J., Gardner W. R., Tigertt W. D. Malaria chemoprophylaxis with 4,4' diaminodiphenylsulfone (DDS). II. Field trial with comparison between two divisions. Mil Med. 1969 Jul;134(7):497–501. [PubMed] [Google Scholar]
  10. Joy R. J., McCarty J. E., Tigertt W. D. Malaria chemoprophylaxis with 4,4' diaminodiphenylsulfone (DDS). I. Field trial with comparison among companies of one division. Mil Med. 1969 Jul;134(7):493–496. [PubMed] [Google Scholar]
  11. Martin D. C., Arnold J. D., Clyde D. F., al-Ibrahim M., Carson P. E., Rieckmann K. H., Willerson D., Jr A quinoline methanol (WR 30090) for treatment of acute malaria. Antimicrob Agents Chemother. 1973 Feb;3(2):214–219. doi: 10.1128/aac.3.2.214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Martin D. C., Arnold J. D. Trimethoprim in therapy of acute attacks of malaria. J Clin Pharmacol J New Drugs. 1967 Nov-Dec;7(6):336–341. doi: 10.1002/j.1552-4604.1967.tb00076.x. [DOI] [PubMed] [Google Scholar]
  13. Ognibene A. J. Agranulocytosis due to dapsone. Ann Intern Med. 1970 Apr;72(4):521–524. doi: 10.7326/0003-4819-72-4-521. [DOI] [PubMed] [Google Scholar]
  14. Tigertt W. D. The army malaria research program. Ann Intern Med. 1969 Jan;70(1):150–153. doi: 10.7326/0003-4819-70-1-150. [DOI] [PubMed] [Google Scholar]
  15. Willerson D., Jr, Rieckmann K. H., Kass L., Carson P. E., Frischer H., Bowman J. E. The chemoprophylactic use of diformyl diaminodiphenyl sulfone (DFD) in falciparum malaria. Am J Trop Med Hyg. 1972 Mar;21(2):138–143. doi: 10.4269/ajtmh.1972.21.138. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES